Atlas Trials

Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia

Clinical trial NCT01506765 · COMPLETED

Trial details

NCT number
NCT01506765
Sponsor
Centre Hospitalier Universitaire Vaudois
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2003-08-01
Primary completion
2004-12-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.